591 results on '"Sander, Leif"'
Search Results
2. Non-HACEK gram-negative bacilli infective endocarditis: data from a retrospective German cohort study
3. Monocyte-derived macrophages are too much of a good thing in lung fibrosis
4. Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19
5. Clinical spectrum and long-term outcomes of mpox: a cohort study spanning from acute infection to six-month follow-up
6. Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)
7. Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
8. 90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection
9. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study*
10. Nachhaltige Strategien gegen die COVID-19-Pandemie in Deutschland im Winter 2021/2022
11. The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
12. Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases
13. Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19
14. The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation
15. CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity
16. Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses
17. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01
18. Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma
19. Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study
20. Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
21. Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19
22. Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis
23. Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies
24. Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents
25. A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study
26. Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
27. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
28. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19
29. Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease
30. Impfen bei pneumologischen Erkrankungen – Teil 2: RSV, Pneumokokken, Pertussis und Herpes Zoster.
31. Levels of high-sensitive troponin T and mid-regional proadrenomedullin after COVID-19 vaccination in vulnerable groups: monitoring cardiovascular safety of COVID-19 vaccination.
32. A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms.
33. Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19
34. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months
35. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
36. The human host response to monkeypox infection: a proteomic case series study
37. Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: a prospective study on subtle and persistent cardiovascular involvement
38. Infektiologie – eine neue Facharztdisziplin in Deutschland
39. Role of the complement system in Long COVID
40. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
41. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01
42. Noncoding RNA MaIL1 is an integral component of the TLR4–TRIF pathway
43. A time-resolved proteomic and prognostic map of COVID-19
44. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany
45. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021
46. Nonproductive exposure of PBMCs to SARS‐CoV‐2 induces cell‐intrinsic innate immune responses
47. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity
48. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19
49. Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
50. Impfen bei pneumologischen Erkrankungen – was, wann und wie?: Teil 1: Covid und Influenza.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.